Glythera Announces Corporate Name Change and Rebranding to Iksuda Therapeutics September 10, 2018 2018
Positive Outcome of Proof-of-Concept Study with Glythera and Follow on Drug Development Partnership January 15, 2018 2018
Glythera licenses novel payload class from Cancer Research UK for the development of next-generation antibody drug conjugates September 26, 2017 Library
Glythera and IONTAS enter into license agreement for the development of multiple antibodies for next-generation Antibody Drug Conjugates September 20, 2017 Library
Glythera launches UK government funded project to develop safer and more efficacious ADCs for the treatment of difficult-to-treat tumours June 6, 2017 Library
